211 related articles for article (PubMed ID: 37531222)
1. Targeted Glioblastoma Treatment via Synthesis and Functionalization of Gold Nanoparticles With De Novo-Engineered Transferrin-Like Peptides: Protocol for a Novel Method.
Müller Fiedler A; Medeiros M; Fiedler HD
JMIR Res Protoc; 2023 Aug; 12():e49417. PubMed ID: 37531222
[TBL] [Abstract][Full Text] [Related]
2. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R
Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060
[TBL] [Abstract][Full Text] [Related]
3. Engineered Aurotherapy for the Multimodal Treatment of Glioblastoma.
Kim HS; Lee DY
Brain Tumor Res Treat; 2022 Oct; 10(4):215-220. PubMed ID: 36347635
[TBL] [Abstract][Full Text] [Related]
4. A comparison of gold nanoparticle surface co-functionalization approaches using Polyethylene Glycol (PEG) and the effect on stability, non-specific protein adsorption and internalization.
Harrison E; Nicol JR; Macias-Montero M; Burke GA; Coulter JA; Meenan BJ; Dixon D
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():710-8. PubMed ID: 26952476
[TBL] [Abstract][Full Text] [Related]
5. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
[TBL] [Abstract][Full Text] [Related]
7. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.
Sandbhor P; Goda J; Mohanty B; Chaudhari P; Dutt S; Banerjee R
Nanoscale; 2021 Dec; 14(1):108-126. PubMed ID: 34897360
[TBL] [Abstract][Full Text] [Related]
9. A recent insight of applications of gold nanoparticles in glioblastoma multiforme therapy.
Qureshi S; Anjum S; Hussain M; Sheikh A; Gupta G; Almoyad MAA; Wahab S; Kesharwani P
Int J Pharm; 2024 Jun; 660():124301. PubMed ID: 38851411
[TBL] [Abstract][Full Text] [Related]
10. Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma.
Ramalho MJ; Loureiro JA; Coelho MAN; Pereira MC
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214012
[TBL] [Abstract][Full Text] [Related]
11. Transferrin-Conjugated PLGA Nanoparticles for Co-Delivery of Temozolomide and Bortezomib to Glioblastoma Cells.
Ramalho MJ; Torres ID; Loureiro JA; Lima J; Pereira MC
ACS Appl Nano Mater; 2023 Aug; 6(15):14191-14203. PubMed ID: 37588263
[TBL] [Abstract][Full Text] [Related]
12. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
[TBL] [Abstract][Full Text] [Related]
13. Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumors.
Stephen ZR; Kievit FM; Veiseh O; Chiarelli PA; Fang C; Wang K; Hatzinger SJ; Ellenbogen RG; Silber JR; Zhang M
ACS Nano; 2014 Oct; 8(10):10383-95. PubMed ID: 25247850
[TBL] [Abstract][Full Text] [Related]
14. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
Sukumar UK; Bose RJC; Malhotra M; Babikir HA; Afjei R; Robinson E; Zeng Y; Chang E; Habte F; Sinclair R; Gambhir SS; Massoud TF; Paulmurugan R
Biomaterials; 2019 Oct; 218():119342. PubMed ID: 31326657
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Characterization of Novel Co-Polymers Decorated with Peptides for the Selective Nanoparticle Transport across the Cerebral Endothelium.
Falanga AP; Melone P; Cagliani R; Borbone N; D'Errico S; Piccialli G; Netti PA; Guarnieri D
Molecules; 2018 Jul; 23(7):. PubMed ID: 29986452
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
[TBL] [Abstract][Full Text] [Related]
18. Investigation on the effect of nanoparticle size on the blood-brain tumour barrier permeability by in situ perfusion via internal carotid artery in mice.
Kang JH; Cho J; Ko YT
J Drug Target; 2019 Jan; 27(1):103-110. PubMed ID: 29972326
[TBL] [Abstract][Full Text] [Related]
19. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers.
Delello Di Filippo L; Hofstätter Azambuja J; Paes Dutra JA; Tavares Luiz M; Lobato Duarte J; Nicoleti LR; Olalla Saad ST; Chorilli M
Eur J Pharm Biopharm; 2021 Nov; 168():76-89. PubMed ID: 34461214
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeled Gold Nanoseeds Decorated with Substance P Peptides: Synthesis, Characterization and In Vitro Evaluation in Glioblastoma Cellular Models.
Silva F; D'Onofrio A; Mendes C; Pinto C; Marques A; Campello MPC; Oliveira MC; Raposinho P; Belchior A; Di Maria S; Marques F; Cruz C; Carvalho J; Paulo A
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
